Form 4: Carlyle Group Sells Additional Shares of QuidelOrtho Corp (QDEL)

The Carlyle Group continues to reduce its stake in QuidelOrtho Corp, selling shares through a pre-arranged trading plan.

Summary

• The Carlyle Group, a significant shareholder of QuidelOrtho Corp (QDEL), has reported the sale of common stock on July 16 and 17, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• On July 16, 2024, a total of 94,861 shares were sold at weighted average prices ranging from $31.7621 to $34.13.
• On July 17, 2024, a total of 69,637 shares were sold at weighted average prices ranging from $34.7927 to $35.0343.
• Following these transactions, the Carlyle Group's indirect ownership stands at 10,730,064 shares.
• The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P., with various entities within the Carlyle Group structure potentially deemed to share beneficial ownership.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting transactions. The impact on sentiment depends on investor interpretation of the Carlyle Group's actions.

Risks

• Continued sales by the Carlyle Group could exert downward pressure on QDEL's stock price.

Future Outlook

The document does not provide a future outlook for QuidelOrtho Corp.

Industry Context

Share sales by major holders are common and can reflect portfolio adjustments or profit-taking. The impact on the stock price depends on the size of the sale relative to trading volume and overall market sentiment.

Stakeholder Impact

• Shareholders may react to the news of the Carlyle Group's share sales.
• The sales could potentially influence the stock price in the short term.

Key Dates